pyrazines has been researched along with Coronary Occlusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, GB; Jain, MK; Lin, Z; Nayak, L; Schmaier, AH; Shi, H | 1 |
| Gao, Q; Huang, W; Su, M; Yang, Y; Zeng, Z; Zhu, B | 1 |
2 other study(ies) available for pyrazines and Coronary Occlusion
| Article | Year |
|---|---|
The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2).
Topics: Animals; Boronic Acids; Bortezomib; Carotid Artery Thrombosis; Cells, Cultured; Coronary Occlusion; Cytoprotection; Human Umbilical Vein Endothelial Cells; Humans; Kruppel-Like Transcription Factors; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrazines; Whole Blood Coagulation Time | 2014 |
Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury.
Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Coronary Occlusion; Coronary Vessels; Creatine Kinase; Gene Expression Regulation; Humans; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Rats; Reperfusion Injury; Salvia miltiorrhiza; Signal Transduction | 2016 |